期刊
BRITISH JOURNAL OF DERMATOLOGY
卷 161, 期 5, 页码 987-1019出版社
WILEY
DOI: 10.1111/j.1365-2133.2009.09505.x
关键词
adalimumab; biologics; efalizumab; etanercept; guideline; infliximab; psoriasis; ustekinumab